Clinical Trials for Irritable Bowel Syndrome With Constipation (IBS-C)

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

NCT ID: NCT05905926

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

NCT ID: NCT05643534

This clinical trial is studying a new treatment called tenapanor for young people aged 12 to under 18 years who have Irritable Bowel Syndrome with Constipation (IBS-C). The main goal is to see if t...